Skip to content

Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings

Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02837536
Enrollment
107
Registered
2016-07-19
Start date
2016-06-23
Completion date
2016-12-23
Last updated
2017-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraocular Pressure

Brief summary

The goal of this study is to evaluate the agreement between intraocular pressure (IOP) measurements taken by iCare, held in both vertical and horizontal positions. In addition, iCare measurements will be compared against pneumotonometry measurements to assess for accuracy.

Interventions

OTHERHorizontal iCare

IOP of the right eye will be measured using the iCare tonometer held in the horizontal position first and then in the vertical position.

OTHERVertical iCare

IOP of the right eye will be measured using the iCare tonometer held in the vertical position first and then in the horizontal position.

Sponsors

Robert Cizik Eye Clinic
CollaboratorOTHER
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older * Must be able to understand and sign and informed consent form that has been approved by an Institutional Review Board/Ethics Committee

Exclusion criteria

* Evidence of corneal epithelial defects or pathology affecting corneal rigidity * Use of topical ophthalmic medications (except for artificial tears) * History or corneal surgeries * Any condition that would prevent or inhibit intraocular pressure measurements using iCare or pneumotonometry * Evidence of ocular infection 30 days prior to enrollment * Allergy to proparacaine or latex

Design outcomes

Primary

MeasureTime frame
IOP taken by iCare - horizontal1 Day
IOP taken by iCare - vertical1 Day
IOP taken by pneumatonometer1 Day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026